Post-Surgical Natural Killer T Cell Activation as a Potential Therapy for Metastatic Breast Cancer

Natural Killer T (NKT) cells are a specialized group of immune-regulatory T lymphocytes. NKT cells have been shown to limit primary tumor growth and target distant metastatic disease in murine cancer models and in human clinical trials. The focus of this work was to utilize NKT cell activation as a...

Full description

Bibliographic Details
Main Author: Clattenburg, Daniel
Language:en
Published: 2013
Online Access:http://hdl.handle.net/10222/15952
id ndltd-LACETR-oai-collectionscanada.gc.ca-NSHD.ca#10222-15952
record_format oai_dc
spelling ndltd-LACETR-oai-collectionscanada.gc.ca-NSHD.ca#10222-159522013-02-06T03:11:23ZPost-Surgical Natural Killer T Cell Activation as a Potential Therapy for Metastatic Breast CancerClattenburg, DanielNatural Killer T (NKT) cells are a specialized group of immune-regulatory T lymphocytes. NKT cells have been shown to limit primary tumor growth and target distant metastatic disease in murine cancer models and in human clinical trials. The focus of this work was to utilize NKT cell activation as a post-surgical immunotherapy in models of metastatic breast cancer. In our model, mammary carcinoma cells were injected into the mammary fat pad of syngeneic mice and primary tumors were resected twelve days later. The following day, mice were treated with NKT cell-activating glycolipids or glycolipid-loaded dendritic cells (DCs) to examine the effect on metastatic disease. Treatment with free glycolipids transiently reduced metastatic disease but did not enhance survival. In contrast, treatment with glycolipid-loaded DCs was effective in limiting metastasis, prolonging survival, and decreasing tumor-associated immune suppression. Our data suggest that NKT cell activation via transfer of glycolipid-loaded self-DCs holds promise as an immunotherapy for metastatic breast cancer.2013-02-04T18:31:55Z2013-02-04T18:31:55Z2013-02-042012-12-14http://hdl.handle.net/10222/15952en
collection NDLTD
language en
sources NDLTD
description Natural Killer T (NKT) cells are a specialized group of immune-regulatory T lymphocytes. NKT cells have been shown to limit primary tumor growth and target distant metastatic disease in murine cancer models and in human clinical trials. The focus of this work was to utilize NKT cell activation as a post-surgical immunotherapy in models of metastatic breast cancer. In our model, mammary carcinoma cells were injected into the mammary fat pad of syngeneic mice and primary tumors were resected twelve days later. The following day, mice were treated with NKT cell-activating glycolipids or glycolipid-loaded dendritic cells (DCs) to examine the effect on metastatic disease. Treatment with free glycolipids transiently reduced metastatic disease but did not enhance survival. In contrast, treatment with glycolipid-loaded DCs was effective in limiting metastasis, prolonging survival, and decreasing tumor-associated immune suppression. Our data suggest that NKT cell activation via transfer of glycolipid-loaded self-DCs holds promise as an immunotherapy for metastatic breast cancer.
author Clattenburg, Daniel
spellingShingle Clattenburg, Daniel
Post-Surgical Natural Killer T Cell Activation as a Potential Therapy for Metastatic Breast Cancer
author_facet Clattenburg, Daniel
author_sort Clattenburg, Daniel
title Post-Surgical Natural Killer T Cell Activation as a Potential Therapy for Metastatic Breast Cancer
title_short Post-Surgical Natural Killer T Cell Activation as a Potential Therapy for Metastatic Breast Cancer
title_full Post-Surgical Natural Killer T Cell Activation as a Potential Therapy for Metastatic Breast Cancer
title_fullStr Post-Surgical Natural Killer T Cell Activation as a Potential Therapy for Metastatic Breast Cancer
title_full_unstemmed Post-Surgical Natural Killer T Cell Activation as a Potential Therapy for Metastatic Breast Cancer
title_sort post-surgical natural killer t cell activation as a potential therapy for metastatic breast cancer
publishDate 2013
url http://hdl.handle.net/10222/15952
work_keys_str_mv AT clattenburgdaniel postsurgicalnaturalkillertcellactivationasapotentialtherapyformetastaticbreastcancer
_version_ 1716576569750716416